Archives of Clinical Infectious Diseases
Urinary tract infections (UTIs) are among the most commonly bacterial infections in clinical practice.Almost half of all women experience at least one urinary tract infection in their lifetime. This study compared efficacy and safety of 3-day and 7-day ciprofloxacin regimen for the treatment of uncomplicated urinary tract infection in women.
A total of 76 patients were randomly assigned to two treatment groups. One group received ciprofloxacin, 250 mg twice a day for 3 days (n=39) and the other group received ciprofloxacin 250 mg twice a day for 7 days (n=37). Subjects were visited and assessed three times during the study period (baseline, end of treatment, and test for cure). Clinical and bacteriological responses to the treatment were compared between the two groups.
There was no significant difference between the two groups in terms of age distribution and clinical signs/symptoms during the baseline visit. There was no significant difference between clinical or bacteriological responses between the two groups. Three-day regimen of ciprofloxacin showed high microbiological eradication rate for E. coli (66.7%) which was similar to the eradication rate observed for 7-day regimen (64.8%). No statistically significant difference was found in adverse effects between the groups, except for nausea (p=0.041).
A 3-day ciprofloxacin regimen appeared to be safe and effective for the treatment of UTI in women. Therefore, shorter therapy duration with ciprofloxacin can potentially improve patient compliance and decrease costs.
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Iranzad M, Hakemi-Vala M. The Role of parC, parE, and qnrB Genes in Ciprofloxacin-Resistant Escherichia coli Isolates from Urinary Tract Infections. Arch Pediatr Infect Dis. 2017;5(3):e41504. doi: https://doi.org/10.5812/pedinfect.41504
Ebrahimzadeh A, Saadatjoo SA, Alipoor Tabrizi A. Comparing Ceftriaxone and Cefazolin for Treatment of Adult Acute Pyelonephritis; A Clinical Trial. Arch Clin Infect Dis. 2010;5(2):. doi:
Malakuti N, Mohajeri S, Raeisi Shahraki H, Salehifardjouneghani A. Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial. Jundishapur J Nat Pharm Prod. 2025;20(4):e165012. doi: https://doi.org/10.5812/jjnpp-165012
Amin M, Mehdinejad M, Pourdangchi Z. Study of bacteria isolated from urinary tract infections and determination of their susceptibility to antibiotics. Jundishapur J Microbiol. 2009;2(3):. doi:
Asgari A, Qaletaaki R, Ranjbar H, Jalaeikhoo H, Hamidi-Farahani R, et al. Efficacy of Ciprofloxacin in Prevention of Sepsis Among the Patients with Chemotherapy-Induced Neutropenia: A Randomized Double-Blind Clinical Trial in a University Hospital in Tehran, Iran. Ann Mil Health Sci Res. 2022;20(3):e130618. doi: https://doi.org/10.5812/amh-130618
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
